Teresa Helsten

4.3k total citations · 1 hit paper
31 papers, 1.2k citations indexed

About

Teresa Helsten is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Teresa Helsten has authored 31 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 14 papers in Pulmonary and Respiratory Medicine and 8 papers in Cancer Research. Recurrent topics in Teresa Helsten's work include Advanced Breast Cancer Therapies (9 papers), Cancer Genomics and Diagnostics (6 papers) and Fibroblast Growth Factor Research (4 papers). Teresa Helsten is often cited by papers focused on Advanced Breast Cancer Therapies (9 papers), Cancer Genomics and Diagnostics (6 papers) and Fibroblast Growth Factor Research (4 papers). Teresa Helsten collaborates with scholars based in United States, Netherlands and France. Teresa Helsten's co-authors include Razelle Kurzrock, Sheryl K. Elkin, Brett N. Tomson, Jennifer Carter, Maria Schwaederlé, Richard B. Schwab, Barbara A. Parker, Paul T. Fanta, David Piccioni and Gregory A. Daniels and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Teresa Helsten

30 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The FGFR Landscape in Cancer: Analysis of 4,853 Tumors by Next-Generation Sequencing

2015 589 citations Teresa Helsten, Sheryl K. Elkin et al. Clinical Cancer Research profile →

Peers

Countries citing papers authored by Teresa Helsten

Since Specialization

Citations

This map shows the geographic impact of Teresa Helsten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Teresa Helsten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Teresa Helsten more than expected).

Fields of papers citing papers by Teresa Helsten

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Teresa Helsten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Teresa Helsten. The network helps show where Teresa Helsten may publish in the future.

Co-authorship network of co-authors of Teresa Helsten

This figure shows the co-authorship network connecting the top 25 collaborators of Teresa Helsten. A scholar is included among the top collaborators of Teresa Helsten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Teresa Helsten. Teresa Helsten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Abemaciclib in combination with therapies for patients with metastatic breast cancer: a phase 1b study 2025 ·Frontiers in Oncology ·Sara M. Tolaney, Komal Jhaveri, Teresa Helsten, Shannon L. Puhalla, Alison Conlin, (unknown), Muralidhar Beeram, Sonya C. Chapman, Andrew Lithio, Lacey M. Litchfield, Matthew P. Goetz	0
2	A phase 1b study of zilovertamab in combination with paclitaxel for locally advanced/unresectable or metastatic HER2-negative breast cancer 2024 ·Breast Cancer Research ·Rebecca Shatsky, (unknown), Teresa Helsten, Richard B. Schwab, Emily Pittman, Minya Pu, Elizabeth Weihe, Emanuela M. Ghia, Laura Z. Rassenti, Alfredo Molinolo, Betty L. Cabrera, James B. Breitmeyer, George F. Widhopf, Karen Messer, Catriona Jamieson, Thomas J. Kipps, Barbara A. Parker	7
3	Let's TOC Fertility: A stepped wedge cluster randomized controlled trial of the Telehealth Oncofertility Care (TOC) intervention in children, adolescent and young adult cancer survivors 2024 ·Contemporary Clinical Trials ·Sally A.D. Romero, (unknown), (unknown), Teresa Helsten, (unknown), Bonnie N. Kaiser, (unknown), (unknown), (unknown), Jingjing Zou, Paula Aristizabal, Saro H. Armenian, H. Irene Su	1
4	Association of physician burnout with perceived EHR work stress and potentially actionable factors 2023 ·Journal of the American Medical Informatics Association ·Ming Tai‐Seale, Sally L. Baxter, Marlene Millen, (unknown), Sidney Zisook, (unknown), (unknown), Bryan K. Sun, (unknown), Teresa Helsten, Rebecca Rosen, Brian Clay, Christine A. Sinsky, Douglas Ziedonis, Chris Longhurst, Thomas J. Savides	19
5	Development, Usability Testing, and Implementation Assessment of Cancer Related Infertility Score Predictor, an Online Cancer Related Infertility Risk Counseling Tool 2023 ·Journal of Adolescent and Young Adult Oncology ·(unknown), (unknown), (unknown), (unknown), (unknown), Teresa Helsten, Bonnie N. Kaiser, Sally A.D. Romero, H. Irene Su	1
6	A Multicomponent Telehealth Intervention to Improve Oncofertility Care Delivery Among Young Cancer Patients: A Pilot Study 2022 ·Journal of Adolescent and Young Adult Oncology ·(unknown), (unknown), (unknown), Teresa Helsten, Bonnie N. Kaiser, Paula Aristizabal, Saro H. Armenian, (unknown), (unknown), (unknown), H. Irene Su, Sally A.D. Romero	3
7	Abemaciclib in Combination With Endocrine Therapy for Patients With Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: A Phase 1b Study 2022 ·Frontiers in Oncology ·Sara M. Tolaney, Muralidhar Beeram, J. Thaddeus Beck, Alison Conlin, Elizabeth Claire Dees, Shannon L. Puhalla, Brent N. Rexer, Howard A. Burris, Komal Jhaveri, Teresa Helsten, Carlos Becerra, Kevin Kalinsky, Kathleen N. Moore, Allison M. Manuel, Andrew Lithio, Gregory L. Price, Sonya C. Chapman, Lacey M. Litchfield, Matthew P. Goetz	11
8	Theory-Guided Development of Fertility Care Implementation Strategies for Adolescent and Young Adult Cancer Survivors 2021 ·Journal of Adolescent and Young Adult Oncology ·(unknown), (unknown), (unknown), (unknown), Paula Aristizabal, (unknown), Teresa Helsten, (unknown), Sally A.D. Romero, Bonnie N. Kaiser, H. Irene Su	4
9	Abstract LB255: Phase 1b trial of cirmtuzumab and paclitaxel for locally advanced, unresectable and metastatic breast cancer 2021 ·Tumor Biology ·Rebecca Shatsky, Karen Messer, Teresa Helsten, Richard B. Schwab, Emily Pittman, Ruifeng Chen, Elizabeth Weihe, George F. Widhopf, (unknown), Laura Z. Rassenti, (unknown), James B. Breitmeyer, Catriona Jamieson, Thomas J. Kipps, Barbara A. Parker	1
10	Next-Generation Sequencing of Tissue and Circulating Tumor DNA: The UC San Diego Moores Center for Personalized Cancer Therapy Experience with Breast Malignancies 2019 ·Molecular Cancer Therapeutics ·Rebecca Shatsky, Barbara A. Parker, Nam Q. Bui, Teresa Helsten, Richard B. Schwab, Sarah G Boles, Razelle Kurzrock	34
11	Cell-Cycle Gene Alterations in 4,864 Tumors Analyzed by Next-Generation Sequencing: Implications for Targeted Therapeutics 2016 ·Molecular Cancer Therapeutics ·Teresa Helsten, Shumei Kato, Maria Schwaederlé, Brett N. Tomson, Timon P.H. Buys, Sheryl K. Elkin, Jennifer Carter, Razelle Kurzrock	34
12	Precision Oncology: The UC San Diego Moores Cancer Center PREDICT Experience 2016 ·Molecular Cancer Therapeutics ·Maria Schwaederlé, Barbara A. Parker, Richard B. Schwab, Gregory A. Daniels, David Piccioni, Santosh Kesari, Teresa Helsten, Lyudmila Bazhenova, (unknown), Paul T. Fanta, Scott M. Lippman, Razelle Kurzrock	125
13	A phase 1b study of abemaciclib, an inhibitor of CDK4 and CDK6, in combination with endocrine and HER2-targeted therapies for patients with metastatic breast cancer 2016 ·Annals of Oncology ·M. Beeram, Sara M. Tolaney, J. Thaddeus Beck, Maura N. Dickler, Alison Conlin, (unknown), Teresa Helsten, Paul Conkling, William J. Edenfield, Donald Richards, (unknown), (unknown), (unknown), Shubham Pant, Kevin Kalinsky, Howard A. Burris, Carlos Becerra, Brent N. Rexer, Shannon L. Puhalla, Matthew P. Goetz	8
14	The FGFR Landscape in Cancer: Analysis of 4,853 Tumors by Next-Generation Sequencing breakdown → 2015 ·Clinical Cancer Research ·Teresa Helsten, Sheryl K. Elkin, (unknown), Brett N. Tomson, Jennifer Carter, Razelle Kurzrock	589
15	Fibroblast growth factor receptor signaling in hereditary and neoplastic disease: biologic and clinical implications 2015 ·Cancer and Metastasis Reviews ·Teresa Helsten, Maria Schwaederlé, Razelle Kurzrock	103
16	Precision oncology: the UC San Diego Moores Cancer Center PREDICT experience. 2015 ·Journal of Clinical Oncology ·Barbara A. Parker, Maria Schwaederlé, Richard B. Schwab, Gregory A. Daniels, David Piccioni, Teresa Helsten, Lyudmila Bazhenova, Paul T. Fanta, Scott M. Lippman, Razelle Kurzrock	2
17	Concurrent intrathecal methotrexate and liposomal cytarabine for leptomeningeal metastasis from solid tumors: a retrospective cohort study 2014 ·Journal of Neuro-Oncology ·Brian J. Scott, Vincent A Van Vugt, Toni Rush, Tiffany A. Brown, Clark C. Chen, Bob S. Carter, Richard B. Schwab, Paul T. Fanta, Teresa Helsten, Lyudmila Bazhenova, Barbara A. Parker, Sandeep C. Pingle, Marlon Garzo Saria, (unknown), David Piccioni, Santosh Kesari	21
18	The FGFR landscape in cancer: An analysis of 4,869 cases. 2014 ·Journal of Clinical Oncology ·Teresa Helsten, Sheryl K. Elkin, Jennifer Carter, Razelle Kurzrock	3
19	Differences in Regulation of Drosophila and Vertebrate Integrin Affinity by Talin 2008 ·Molecular Biology of the Cell ·Teresa Helsten, Thomas A. Bunch, Hisashi Kato, Jun Yamanouchi, Sharon H. Choi, (unknown), Chloé C. Féral, Mark H. Ginsberg, Danny L. Brower, Sanford J. Shattil	26
20	Amino Acid Changes in Drosophila αPS2βPS Integrins That Affect Ligand Affinity 2005 ·Journal of Biological Chemistry ·Thomas A. Bunch, Teresa Helsten, Timmy Kendall, Nikhil Shirahatti, Daruka Mahadevan, Sanford J. Shattil, Danny L. Brower	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact